Inactive Instrument
CTT Pharmaceutical Holdings, Inc. Stock Other OTC
Stocks
CTTH
US12651E1064
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.28M 2.92M 2.72M 2.48M 4.68M 316M 4.73M 32.96M 12.77M 161M 12.33M 12.06M 518M | P/E 2024 |
-11.9x | P/E 2025 | -22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.29M 2.92M 2.73M 2.49M 4.69M 316M 4.73M 33M 12.79M 162M 12.35M 12.08M 519M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
50.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -22.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 71 | 09/09/2014 |
Ryan Khouri
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -22.52% | -0.09% | - | - | 3.28M | ||
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | ||
| -3.11% | -3.53% | +20.19% | +79.01% | 57.39B | ||
| +0.89% | -0.63% | +2.17% | +35.99% | 47.64B | ||
| +0.36% | +0.81% | +342.39% | +748.97% | 44.29B | ||
| -0.96% | -4.50% | +24.96% | +31.45% | 42.5B | ||
| -0.20% | -0.77% | +4.13% | +111.69% | 40.71B | ||
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | ||
| +1.83% | +3.84% | +32.02% | +29.25% | 28.53B | ||
| +0.05% | -1.64% | -8.14% | -12.10% | 24.34B | ||
| Average | -2.02% | -0.59% | +52.93% | +130.28% | 43.39B | |
| Weighted average by Cap. | +0.44% | -0.84% | +57.15% | +139.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -250K -222K -208K -189K -357K -24.06M -360K -2.51M -973K -12.3M -939K -919K -39.47M | -156K -139K -129K -118K -222K -14.99M -224K -1.56M -606K -7.66M -585K -573K -24.59M |
| Net Debt | 16.82K 14.94K 13.95K 12.71K 23.98K 1.62M 24.2K 169K 65.41K 827K 63.15K 61.78K 2.65M | 3.46K 3.07K 2.87K 2.61K 4.93K 332K 4.97K 34.67K 13.44K 170K 12.97K 12.69K 545K |
Employees
-
















